Restoration of cone vision in a mouse model of achromatopsia
- 21 May 2007
- journal article
- research article
- Published by Springer Nature in Nature Medicine
- Vol. 13 (6) , 685-687
Abstract
Loss of cone function in the central retina is a pivotal event in the development of severe vision impairment for many prevalent blinding diseases. Complete achromatopsia is a genetic defect resulting in cone vision loss in 1 in 30,000 individuals. Using adeno-associated virus (AAV) gene therapy, we show that it is possible to target cones and rescue both the cone-mediated electroretinogram response and visual acuity in the Gnat2cpfl3 mouse model of achromatopsia.Keywords
This publication has 13 references indexed in Scilit:
- Hypoglycemia leads to age-related loss of visionProceedings of the National Academy of Sciences, 2006
- CNGB3 mutations account for 50% of all cases with autosomal recessive achromatopsiaEuropean Journal of Human Genetics, 2004
- Molecular genetics of color-vision deficienciesVisual Neuroscience, 2004
- Achromatopsia caused by novel mutations in both CNGA3 and CNGB3Journal of Medical Genetics, 2004
- Comparative analysis of transcriptional profiles between two apoptotic pathways of light-induced retinal degenerationNeuroscience, 2004
- Mouse cone arrestin expression pattern: light induced translocation in cone photoreceptors.2002
- Mutations in the Cone Photoreceptor G-Protein α-Subunit Gene GNAT2 in Patients with AchromatopsiaThe American Journal of Human Genetics, 2002
- Role of a locus control region in the mutually exclusive expression of human red and green cone pigment genesProceedings of the National Academy of Sciences, 2002
- A locus control region adjacent to the human red and green visual pigment genesNeuron, 1992
- Molecular Genetics of Human Blue Cone MonochromacyScience, 1989